Theratechnologies Reports on its Annual Meeting of Shareholders [Yahoo! Finance]
Theratechnologies Reports on its Annual Meeting of Shareholders [Financial Post (Toronto, Ontario, Canada)]
Theratechnologies Reports on its Annual Meeting of Shareholders
Theratechnologies to Present Long-Term Efficacy, Safety and Pharmacokinetic Data on Use of TH1902 (sudocetaxel zendusortide) in Solid Tumors at 2024 ASCO Meeting [Financial Post (Toronto, Ontario, Canada)]
Theratechnologies to Present Long-Term Efficacy, Safety and Pharmacokinetic Data on Use of TH1902 (sudocetaxel zendusortide) in Solid Tumors at 2024 ASCO Meeting [Yahoo! Finance]